Jiaxin Lin
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Imlifidase and EndoS Enables Haploidentical Bone Marrow Engraftment in Sensitized Mice Under Reduced Intensity Conditioning.
Journal: Transplantation and cellular therapy
Published: September 18, 2025
Long-Term Survival and Induction of Operational Tolerance to Murine Islet Allografts by Co-Transplanting Cyclosporine A Microparticles and CTLA4-Ig.
Journal: Pharmaceutics
Published: August 11, 2023
CD8 T Cells Target Antigen Cross-Presented by Bone Marrow Derived Cells to Induce Bystander Rejection of Grafts Lacking the Cognate Peptide-MHC.
Journal: Cell transplantation
Published: November 11, 2022
Endothelial phosphoinositide 3-kinase-β inactivation confers protection from immune-mediated vascular injury.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 20, 2022
Loss of thymic function promotes EAE relapse in anti-CD52-treated mice.
Journal: Current research in immunology
Published: December 30, 2021
Desensitization using imlifidase and EndoS enables chimerism induction in allosensitized recipient mice.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: January 28, 2020
Anti-CD52 blocks EAE independent of PD-1 signals and promotes repopulation dominated by double-negative T cells and newly generated T and B cells.
Journal: European journal of immunology
Published: July 02, 2019
Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.
Journal: Frontiers in immunology
Published: December 13, 2017
Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1.
Journal: Frontiers in immunology
Published: October 21, 2017
PD-1 Controls Tonic Signaling and Lymphopenia-Induced Proliferation of T Lymphocytes.
Journal: Frontiers in immunology
Published: May 31, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026